Literature DB >> 28263813

Ligand-decorated click polypeptide derived nanoparticles for targeted drug delivery applications.

Mohiuddin A Quadir1, Stephen W Morton1, Lawrence B Mensah1, Kevin Shopsowitz1, Jeroen Dobbelaar1, Nicole Effenberger1, Paula T Hammond2.   

Abstract

A ligand decorated, synthetic polypeptide block copolymer platform with environment-responsive capabilities was designed. We evaluated the potential of this system to function as a polymersome for targeted-delivery of a systemic chemotherapy to tumors. Our system employed click chemistry to provide a pH-responsive polypeptide block that drives nanoparticle assembly, and a ligand (folic acid) conjugated PEG block that targets folate-receptor over-expressing cancer cells. These nanocarriers were found to encapsulate a high loading of conventional chemotherapeutics (e.g. doxorubicin at physiological pH) and release the active therapeutic at lysosomal pH upon cellular uptake. The presence of folic acid on the nanoparticle surface facilitated their active accumulation in folate-receptor-overexpressing cancer cells (KB), compared to untargeted carriers. Folate-targeted nanoparticles loaded with doxorubicin also showed enhanced tumor accumulation in folate-receptor positive KB xenografts, resulting in the suppression of tumor growth in an in vivo hind flank xenograft mouse model.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Block copolymers; Drug delivery; Nanocarriers; Poly (propargyl L-glutamate)

Mesh:

Substances:

Year:  2017        PMID: 28263813      PMCID: PMC5641973          DOI: 10.1016/j.nano.2017.02.010

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  57 in total

Review 1.  Nanoparticle delivery of cancer drugs.

Authors:  Andrew Z Wang; Robert Langer; Omid C Farokhzad
Journal:  Annu Rev Med       Date:  2011-09-01       Impact factor: 13.739

2.  Comparison of nanoparticle penetration into solid tumors and sites of inflammation: studies using targeted and nontargeted liposomes.

Authors:  Scott Poh; Venkatesh Chelvam; Philip S Low
Journal:  Nanomedicine (Lond)       Date:  2015-05       Impact factor: 5.307

3.  Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions.

Authors:  Yuan Yuan; Dag André Nymoen; Hiep Phuc Dong; Ola Bjørang; Ie-Ming Shih; Philip S Low; Claes G Trope'; Ben Davidson
Journal:  Hum Pathol       Date:  2009-05-19       Impact factor: 3.466

4.  Biodegradable and amphiphilic block copolymer-doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy.

Authors:  Yang Yang; Dayi Pan; Kui Luo; Li Li; Zhongwei Gu
Journal:  Biomaterials       Date:  2013-07-27       Impact factor: 12.479

5.  Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas.

Authors:  Jay E Allard; John I Risinger; Carl Morrison; Gregory Young; G Scott Rose; Jeff Fowler; Andrew Berchuck; G Larry Maxwell
Journal:  Gynecol Oncol       Date:  2007-06-20       Impact factor: 5.482

6.  In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.

Authors:  Alberto Gabizon; Aviva T Horowitz; Dorit Goren; Dina Tzemach; Hilary Shmeeda; Samuel Zalipsky
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

7.  The folate receptor in central nervous system malignancies of childhood.

Authors:  S D Weitman; K M Frazier; B A Kamen
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Polyethylene glycol conjugated polymeric nanocapsules for targeted delivery of quercetin to folate-expressing cancer cells in vitro and in vivo.

Authors:  Riham I El-Gogary; Noelia Rubio; Julie Tzu-Wen Wang; Wafa' T Al-Jamal; Maxime Bourgognon; Houmam Kafa; Muniba Naeem; Rebecca Klippstein; Vincenzo Abbate; Frédéric Leroux; Sara Bals; Gustaaf Van Tendeloo; Amany O Kamel; Gehanne A S Awad; Nahed D Mortada; Khuloud T Al-Jamal
Journal:  ACS Nano       Date:  2014-01-23       Impact factor: 15.881

9.  Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers.

Authors:  Daniel J O'Shannessy; Elizabeth B Somers; Li-Chong Wang; Hongwei Wang; Ruby Hsu
Journal:  J Ovarian Res       Date:  2015-05-14       Impact factor: 4.234

10.  Comparison of Folate Receptor Targeted Optical Contrast Agents for Intraoperative Molecular Imaging.

Authors:  Elizabeth De Jesus; Jane J Keating; Sumith A Kularatne; Jack Jiang; Ryan Judy; Jarrod Predina; Shuming Nie; Philip Low; Sunil Singhal
Journal:  Int J Mol Imaging       Date:  2015-09-28
View more
  5 in total

1.  New side chain design for pH-responsive block copolymers for drug delivery.

Authors:  Priyanka Ray; Narendra Kale; Mohiuddin Quadir
Journal:  Colloids Surf B Biointerfaces       Date:  2021-01-06       Impact factor: 5.999

Review 2.  Targeted Cancer Therapy via pH-Functionalized Nanoparticles: A Scoping Review of Methods and Outcomes.

Authors:  Stefan Morarasu; Bianca Codrina Morarasu; Razvan Ghiarasim; Adina Coroaba; Crina Tiron; Radu Iliescu; Gabriel-Mihail Dimofte
Journal:  Gels       Date:  2022-04-11

3.  Spermine modified polymeric micelles with pH-sensitive drug release for targeted and enhanced antitumor therapy.

Authors:  Yang Chen; Cejun Yang; Juan Mao; Haigang Li; Jinsong Ding; Wenhu Zhou
Journal:  RSC Adv       Date:  2019-04-09       Impact factor: 4.036

4.  Redox-Responsive Polymersomes as Smart Doxorubicin Delivery Systems.

Authors:  Carmen Ferrero; Marta Casas; Isidoro Caraballo
Journal:  Pharmaceutics       Date:  2022-08-18       Impact factor: 6.525

Review 5.  Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers.

Authors:  Shruti Rawal; Mayur Patel
Journal:  Nanomicro Lett       Date:  2021-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.